| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| Chemical and physical data | |
| Formula | C9H13N3 |
| Molar mass | 163.224 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
ABT-202 is a drug developed byAbbott, which acts as an agonist at neuralnicotinic acetylcholine receptors and has been researched for use as ananalgesic, although it has not passedclinical trials.[1][2][3]